Antiangiogenic Synergism of Integrin-Targeted Fumagillin Nanoparticles and Atorvastatin in Atherosclerosis

This publication has 42 references indexed in Scilit:

• Minute dosages of α_νβ₃‐targeted fumagillin nanoparticles impair Vx‐2 tumor angiogenesis and development in rabbits
  The FASEB Journal, 2008
• In Vivo Atherosclerotic Plaque Characterization Using Magnetic Susceptibility Distinguishes Symptom-Producing Plaques
  JACC: Cardiovascular Imaging, 2008
• Mechanisms of adverse effects of anti-VEGF therapy for cancer
  British Journal of Cancer, 2007
• Imaging of Vx‐2 rabbit tumors with α_νβ₃‐integrin‐targeted ¹¹¹In nanoparticles
  International Journal of Cancer, 2007
• Statin Treatment Is Not Associated With Consistent Alterations in Inflammatory Status of Carotid Atherosclerotic Plaques
  Stroke, 2006
• Role of Angiogenesis in Cardiovascular Disease
  Circulation, 2005
• Detection of Injury-Induced Vascular Remodeling by Targeting Activated α _v β ₃ Integrin In Vivo
  Circulation, 2004
• The Activation State of αvβ3Regulates Platelet and Lymphocyte Adhesion to Intact and Thrombin-cleaved Osteopontin
  Published by Elsevier ,2000
• Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases
  Journal of Cellular Biochemistry, 2000
• Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470
  New England Journal of Medicine, 1998